Dissecting RNA regulation in single cells and tissues
- Institution
- UNIVERSITY OF CALIFORNIA RIVERSIDE, CA
- Principal investigator
- Adam Norris
- Funding
- $414K
- Duration
- 2019–2029
Moonbase score
Still being scored
Abstract
ABSTRACT The fate and function of individual cells and tissues is often dictated at the transcriptional level by the activity of cell- and tissue-specific transcription factors, as well as by RNA Binding Proteins (RBPs) that determine aspects of mRNA processing such as alternative splicing, stability, and localization. The physiological importance of RBPs in regulating RNA processing is illustrated by many human diseases, for example Spinal Muscular Atrophy and ALS/FTD, which can result from RBP mutation or dysregulation. A major open question for many of these diseases is: why does disruption of a widely-expressed RBP result in highly cell-specific phenotypes? For example, in SMA, why does mutation of the ubiquitously-expressed SMN1 result specifically in motor neuron degeneration? A second major question is: which target(s) of a given RBP are responsible for a specific phenotype? And a third related question: are the physiologically-relevant targets of a given RBP different in different cell or tissue types? Collectively these open questions illustrate that much remains unresolved about the relationship between RBP regulation and function in specific cells and tissues. Thus, we will ask how broadly-expressed RBPs result in highly specific functional outcomes, focusing on cell- specific regulatory mechanisms of two model RBPs, MEC-8/RBPMS and SMN-1. In addition to well-established roles for RBPs in regulating processes such as RNA stability and alternative splicing, the known universe of RNA regulation modalities continues to expand. Our lab is particularly interested in novel types of alternative splicing, aiming to dissect new and emerging types of alternative splicing at the cell-specific level, focusing on (1) formation of circular RNAs (circRNAs) due to back-splicing as opposed to canonical forward splicing, and (2) alternative splicing of exons that are not multiples of 3 nucleotides, and thus may lead to unusual outcomes including amino acid recoding, alternative C-termini lengths, and regulated RNA degradation. Together these experiments will address a significant gap in our understanding of the regulation and function of RNA processing at the cell- and tissue-specific level.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF CALIFORNIA RIVERSIDE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of California Riverside66
Improving outcomes in endovascular treatment of intracranial aneurysms: Combining additive manufacturing, in-silico modeling, and shape memory polymers
Chung-Hao Lee · $686K · 2022–2027
- NIH · University of California Riverside60
Erythrocyte-derived particles for near infrared phototherapy of port wine stains.
Bahman Anvari · $487K · 2016–2027
- NIH · University of California Riverside48
Molecular Markers of Cerebrovascular Pathologies in Alzheimer's Disease and Related Dementias
Denes V. Agoston · $574K · 2024–2028